Back to 
Rafferty Asset Management, LLC
Rafferty Asset Management, LLC
CNSTShowing 0 of 6 quarters
Position history for Rafferty Asset Management, LLC's holdings in CONSTELLATION PHARMACEUTICAL
As of its Q2 2021 13F, Rafferty Asset Management held 55,592 shares of CNST (Constellation Pharmaceutical), worth $1.9M. Rafferty Asset Management's 13F filings listed CNST from Q2 2020 to Q2 2021, 5 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CNST: Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP